These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30627285)

  • 1. Clinical Outcomes of Novel Long-Tapered Sirolimus-Eluting Coronary Stent System in Real-World Patients With Long Diffused
    Patted SV; Jain RK; Jiwani PA; Suryavanshi S; Raghu TR; Raveesh H; Rajalakshmi S; Thakkar AS; Turiya PK; Desai PJ; Patted AS; Sharma KH
    Cardiol Res; 2018 Dec; 9(6):350-357. PubMed ID: 30627285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions.
    Patted SV
    Cardiol Res; 2024 Jun; 15(3):169-178. PubMed ID: 38994223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year outcomes of novel BioMime Morph tapered stent in long and multiple coronary artery lesions.
    Sharma YP; Uppal L; Panda P; Mohanty S; Kasinadhuni G; Krishnappa D; Mehrotra S; Gupta A; Prasad K; Santosh K; Bootla D; Ghosh S
    Anatol J Cardiol; 2021 Dec; 25(12):896-901. PubMed ID: 34866584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in Real-World Population at Single-Center: A Retrospective Observational Study.
    Meennahalli Palleda G; Gupta M; Bansal A; Batra V; Tyagi S; Kunal S
    Cardiol Res; 2023 Oct; 14(5):360-369. PubMed ID: 37936627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Outcomes of Left Main to Branch Vessel PCI with Novel Tapered Coronary Stent in a Tertiary Care Centre: A Real World Experience.
    Raghu TR; Raj VAS; Kharge J; Setty HSN; Patil RS; Manjunath CN
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(2):128-135. PubMed ID: 34387173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes of World's Thinnest (50 μmr) Strut Biodegradable Polymer Coated Everolimus-Eluting Coronary Stent System in Real-World Patients.
    Patted SV; Patted AS; Turiya PK; Thakkar AS
    Cardiol Res; 2018 Dec; 9(6):370-377. PubMed ID: 30627288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world evidence of BioMime sirolimus-eluting stent in obstructive coronary artery disease: the meriT-2 trial.
    Kaul U; Wander GS; Mullasari A; Nanjappa MC; Heggunje-Shetty P; Alexander T; Hardas S; Abraham S; Mathew SK; Vijan S; Manoj RK; Chandra U; Thakkar A
    AsiaIntervention; 2024 Sep; 10(3):186-194. PubMed ID: 39347114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
    Yuan F; Chen X; Song X; Wang D; Zhang Z; Li W; Li Z; Li H; Chen X; Huo Y; Wang L; Lu C; Lu Q; Xu B; Li W; Lyu S;
    Chin Med J (Engl); 2014; 127(14):2561-6. PubMed ID: 25043067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study.
    Jain RK; Chakravarthi P; Shetty R; Ramchandra P; Polavarapu RS; Wander GS; Mohan B; Banker DN; Dharmadhikari A; Bansal SS; Jain N; Solanki D; Dhakaan J; Sharma VP; Mohanan PP; Ashokan PK; Manjunath BV; Hiregoudar N; Patil C; Balakrishnan N
    Indian Heart J; 2016; 68(5):599-603. PubMed ID: 27773396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial.
    Dani S; Costa RA; Joshi H; Shah J; Pandya R; Virmani R; Sheiban I; Bhatt S; Abizaid A
    EuroIntervention; 2013 Aug; 9(4):493-500. PubMed ID: 23965355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial.
    Abizaid A; Kedev S; Kedhi E; Talwar S; Erglis A; Hlinomaz O; Masotti M; Fath-Ordoubadi F; Lemos PA; Milewski K; Botelho R; Costa R; Bangalore S
    EuroIntervention; 2018 Dec; 14(11):e1207-e1214. PubMed ID: 30222120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes from Unselected "Real-World" Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent.
    Polavarapu A; Polavarapu RS; Prajapati J; Thakkar K; Raheem A; Mayall T; Thakkar A
    Scientifica (Cairo); 2015; 2015():613089. PubMed ID: 26579328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].
    Xu LJ; Gao Z; Song Y; Wang HH; Xu JJ; Gao LJ; Zhang Y; Song L; Zhao XY; Chen J; Yuan JQ; Qiao SB; Yang YJ; Xu B; Gao RL;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):523-528. PubMed ID: 30032542
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with 12-month follow-up in patients after implantation of a novel long-tapered sirolimus drug-eluting stent.
    Podolec J; Skubera M; Niewiara Ł; Podolec M; Pieniążek P; Bartuś K; Żmudka K; Legutko J
    Postepy Kardiol Interwencyjnej; 2019; 15(1):46-51. PubMed ID: 31043984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the relation between IVUS measurements and clinical outcome in elderly patients after sirolimus-eluting stent implantation for de novo coronary lesions.
    Du R; Zhang RY; Zhang Q; Shi YH; Hu J; Yang ZK; Ding FH; Zhang JS; Shen WF
    Int J Cardiovasc Imaging; 2012 Oct; 28(7):1653-62. PubMed ID: 22222382
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.